Comprehensive analysis of immune evasion in breast cancer by single-cell RNA-seq

Jianhua Yin, Zhisheng Li, Yan Chen, Enhao Fang, Ting Wang, Hanlin Zhou, Weiwei Luo, Qing Zhou, Jingyu Zhang, Jintao Hu, Haoxuan Jin, Lei Wang, Xing Zhao, Jiguang Li, Xiaojuan Qi, Wenbin Zhou, Chen Huang, Chenyang He, Huanming Yang, Karsten Kristiansen, Yong Hou, Shida Zhu, Dongxian Zhou, Ling Wang, Michael Dean, Kui Wu, Hong Hu, Guibo LibioRxiv 2018 · DOI

TL;DR

This study uses single-cell RNA sequencing to dissect the complex tumor microenvironment (TME) of breast cancer, revealing a diverse landscape of immune and tumor cells. By analyzing over 52,000 cells from 15 patients, the researchers identified intricate interactions between tumor cells, immune cells, and stromal cells that contribute to immune evasion, offering new insights into how breast cancers suppress anti-tumor immunity.

What Problem Does This Paper Address?

Breast cancer is a leading cause of death in women, and its treatment is complicated by its diverse subtypes and the complex interplay within the tumor microenvironment (TME). The TME, a mix of tumor cells, immune cells, and stromal cells, plays a crucial role in cancer progression and response to therapy. While it's known that cancer cells can evade immune surveillance, the precise mechanisms by which this occurs in breast cancer, especially considering the heterogeneity across different subtypes, remain unclear. Understanding this "immune evasion" is critical for developing more effective immunotherapies.

Methods

The core technique employed is single-cell RNA sequencing (scRNA-seq). This allows researchers to analyze the gene expression of individual cells within a tissue sample, providing a high-resolution view of cellular diversity and function.

Key steps and analyses include:

  • Sample Collection and Processing: Tumor tissues from 15 breast cancer patients, representing four major subtypes (luminal A, luminal B, HER2+, and TNBC), were collected. These tissues were then dissociated into single cells for scRNA-seq.
  • scRNA-seq and Data Processing: Libraries were prepared and sequenced, generating transcriptomic data for over 52,000 individual cells. Standard bioinformatics pipelines were used for quality control, filtering, and alignment.
  • Cell Type Identification and Clustering: Unsupervised clustering algorithms (e.g., Seurat package) were used to group cells based on their gene expression profiles. Specific cell markers were then used to annotate these clusters into distinct cell types, including tumor cells, various immune cell populations (T cells, B cells, NK cells, macrophages, dendritic cells), and cancer-associated fibroblasts (CAFs).
  • Tumor Cell Heterogeneity Analysis: The study investigated the diversity within tumor cell populations, analyzing their molecular subtypes and oncogenic pathways using gene set variation analysis (GSVA) and the PAM50 classifier.
  • Intercellular Communication Analysis: A network of potential cell-cell interactions was constructed by analyzing ligand-receptor pairs to understand how different cell types communicate within the TME.
  • Copy Number Variation (CNV) Analysis: InferCNV was used to distinguish tumor cells from non-tumor cells based on their genomic alterations.

Datasets

The study utilized tumor tissue samples from 15 breast cancer patients. These patients represented four distinct molecular subtypes: luminal A, luminal B, HER2+, and triple-negative breast cancer (TNBC). The specific patient identifiers and their clinical/histological profiles are detailed in Table S1. No new benchmark datasets were introduced; the focus was on analyzing the collected patient samples.

Key Insights and Ideas

  • Remarkable Cellular Diversity: The breast cancer TME is far more complex than previously appreciated, with numerous distinct subtypes of immune cells and CAFs identified. This heterogeneity is a key factor in immune evasion.
  • Tumor Cell-Immune Cell Crosstalk: Tumor cells actively engage in communication with immune cells (particularly macrophages and CAFs) to suppress anti-tumor immunity. This interaction is mediated by specific ligand-receptor pairs.
  • Functional Specialization of Immune Cells: Different subtypes of immune cells, especially T cells and macrophages, exhibit specialized functional states (e.g., cytotoxic, exhausted, M2 polarization) that can either promote or hinder anti-tumor responses.
  • Intra-Tumor Heterogeneity: Tumor cells within the same patient can exhibit significant heterogeneity in their gene expression, molecular subtypes, and pathway activation, contributing to varied responses to therapy and immune evasion strategies.
  • HLA-I Expression as a Key Evasion Mechanism: Downregulation of Human Leukocyte Antigen Class I (HLA-I) genes in tumor cells was observed in some samples, correlating with reduced T cell infiltration and suggesting a mechanism for immune escape.

Key Results

  • 52,163 Cells Analyzed: The study profiled the transcriptomes of 52,163 individual cells from 15 breast cancer patients.
  • Identification of Cell Subtypes: The analysis identified multiple distinct clusters and subtypes within immune cells (9 T cell clusters, 5 macrophage clusters, 5 B cell clusters, 2 DC clusters) and CAFs (2 clusters).
  • Functional States of T Cells: Five CD8+ T cell clusters showed varying degrees of activation, cytotoxicity, and exhaustion. Three CD4+ T cell clusters also displayed diverse functional states, including regulatory T cells.
  • Macrophage Polarization: Macrophages were found to be predominantly in the M2 state in some samples, which is associated with promoting tumor growth and suppressing immune responses.
  • Interactions Driving Evasion: Key ligand-receptor interactions, such as CSF1-CSF1R, IGF1-IGF1R, and IL1B-IL1R1 between macrophages and tumor cells, and CXCL12-CXCR4 between CAFs and tumor cells, were identified as potentially mediating immune suppression.
  • HLA-I Downregulation: In samples with low lymphocyte infiltration, HLA-I gene expression was downregulated, suggesting a role in preventing immune cell recognition.

Limitations and Future Work

  • Limited Sample Size: While 15 patients were analyzed, a larger cohort would be beneficial for validating findings and increasing statistical power.
  • Static Snapshot: scRNA-seq provides a snapshot of the TME at a single time point. Dynamic changes and the temporal evolution of cellular interactions are not captured.
  • Need for Validation: Many identified interactions and mechanisms require further experimental validation in vitro and in vivo.
  • Therapeutic Implications: The authors suggest that understanding these cellular interactions and functional states could guide personalized therapy design, such as targeting specific cell populations or pathways to enhance anti-tumor immunity. Future work could focus on developing targeted therapies based on these findings.

Summary updated

Abstract

Abstract The tumor microenvironment is composed of numerous cell types, including tumor, immune and stromal cells. Cancer cells interact with the tumor microenvironment to suppress anticancer immunity. In this study, we molecularly dissected the tumor microenvironment of breast cancer by single-cell RNA-seq. We profiled the breast cancer tumor microenvironment by analyzing the single-cell transcriptomes of 52,163 cells from the tumor tissues of 15 breast cancer patients. The tumor cells and immune cells from individual patients were analyzed simultaneously at the single-cell level. This study explores the diversity of the cell types in the tumor microenvironment and provides information on the mechanisms of escape from clearance by immune cells in breast cancer. One Sentence Summary Landscape of tumor cells and immune cells in breast cancer by single cell RNA-seq
BibTeX
@misc{yin2018comprehensive,
  author = {Jianhua Yin and Zhisheng Li and Yan Chen and Enhao Fang and Ting Wang and Hanlin Zhou and Weiwei Luo and Qing Zhou and Jingyu Zhang and Jintao Hu and Haoxuan Jin and Lei Wang and Xing Zhao and Jiguang Li and Xiaojuan Qi and Wenbin Zhou and Chen Huang and Chenyang He and Huanming Yang and Karsten Kristiansen and Yong Hou and Shida Zhu and Dongxian Zhou and Ling Wang and Michael Dean and Kui Wu and Hong Hu and Guibo Li},
  title = {{Comprehensive analysis of immune evasion in breast cancer by single-cell RNA-seq}},
  year = {2018},
  doi = {10.1101/368605},
  howpublished = {bioRxiv},
}
Figure